Iodide

Iodide

SCHEMBL1411907

I.On1ccccc1=S.[KH].[NaH]

nearest known ligand 0.86

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 known ✓ P11229 1/20 0.86
ESR1 P03372 1/20 0.86
HSP90AA1 P07900 1/20 0.86
MMP3 P08254 1/20 0.86
TBXA2R P21731 1/20 0.86
PTGS1 P23219 1/20 0.86
LOX P28300 1/20 0.86
ADRA1A P35348 1/20 0.86
RAB9A P51151 1/20 0.86
GFER P55789 1/20 0.86
LOXL3 P58215 1/20 0.86
LOXL4 Q96JB6 1/20 0.86
LOXL2 Q9Y4K0 1/20 0.86
KDM4E B2RXH2 1/20 0.43
CA12 O43570 1/20 0.43
USP2 O75604 1/20 0.43
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43
TP53 P04637 1/20 0.43
CA3 P07451 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL144753 0.95
SCHEMBL435760 0.95 ESR1 (0.95) ESR1HSP90AA1MMP3CHRM1TBXA2R
SCHEMBL726811 0.95
SCHEMBL19900041 0.93 ESR1 (0.90) ESR1HSP90AA1MMP3CHRM1TBXA2R
SCHEMBL7054726 0.93 ESR1 (0.90) ESR1HSP90AA1MMP3CHRM1TBXA2R
SCHEMBL8333927 0.93 ESR1 (0.90) ESR1HSP90AA1MMP3CHRM1TBXA2R
SCHEMBL2427022 0.93 ESR1 (1.00) ESR1HSP90AA1MMP3CHRM1TBXA2R
SCHEMBL24755 0.93
SCHEMBL1250766 0.90
Hydrochloric Acid SCHEMBL11149339 0.90 ESR1 (0.95) ESR1HSP90AA1MMP3CHRM1TBXA2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9446009-B2 Methods for treating conditions of the nail unit HALLUX, INC. (US) 2016-09-20 US claimed
US-20140322293-A1 METHODS FOR TREATING CONDITIONS OF THE NAIL UNIT HALLUX, INC. (US) 2014-10-30 US claimed
US-8747820-B2 Methods for treating conditions of the nail unit HALLUX, INC. (US) 2014-06-10 US claimed
US-20140050772-A1 METHODS FOR TREATING CONDITIONS OF THE NAIL UNIT Hallux. Inc. (US) 2014-02-20 US claimed
US-8591870-B2 Compositions and methods for treating conditions of the nail unit HALLUX, INC. (US) 2013-11-26 US claimed
US-8354095-B2 biodegradable drug delivery system; fungal infection; inflammation; injection HALLUX, INC. (US) 2013-01-15 US claimed
US-20110104235-A1 COMPOSITIONS AND METHODS FOR TREATING CONDITIONS OF THE NAIL UNIT TALIMA (ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC 2011-05-05 US claimed
EP-2295036-A2 Liquid compositions and methods for treating conditions of the nail unit Talima Therapeutics, Inc. (US) 2011-03-16 EP claimed
EP-2037880-A2 COMPOSITIONS AND METHODS FOR TREATING CONDITIONS OF THE NAIL UNIT Talima Therapeutics, Inc. (US) 2009-03-25 EP claimed
US-20080132442-A1 COMPOSITIONS AND METHODS FOR TREATING CONDITIONS OF THE NAIL UNIT TALIMA (ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC 2008-06-05 US claimed
WO-2007139804-A2 COMPOSITIONS AND METHODS FOR TREATING CONDITIONS OF THE NAIL UNIT TALIMA THERAPEUTICS, INC. (US) 2007-12-06 WO claimed
EP-1827401-A2 COMPOSITIONS AND METHODS FOR TREATING CONDITIONS OF THE NAIL UNIT Talima Therapeutics, Inc. (US) 2007-09-05 EP claimed
US-20060275230-A1 Compositions and methods for treating conditions of the nail unit TALIMA THERAPEUTICS, INC. 2006-12-07 US claimed
US-20060153786-A1 Compositions and methods for treating conditions of the nail unit TALIMA THERAPEUTICS, INC. (US) 2006-07-13 US claimed
WO-2006063350-A2 COMPOSITIONS AND METHODS FOR TREATING CONDITIONS OF THE NAIL UNIT TALIMA THERAPEUTICS, INC. (US) 2006-06-15 WO claimed
US-11524051-B2 Methods of treating fungal infections THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2022-12-13 US disclosed
US-10946065-B2 Methods of treating fungal infections THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2021-03-16 US disclosed
US-6846837-B2 Topical administration of basic antifungal compositions to treat fungal infections of the nails TECHNOLOGY RECOVERY SYSTEMS, LLC 2005-01-25 US disclosed
WO-2004000291-A1 TOPICAL ADMINISTRATION OF BASIC ANTIFUNGAL COMPOSITIONS TO TREAT FUNGAL INFECTIONS OF THE NAILS DERMATRENDS, INC. (US) 2003-12-31 WO disclosed
US-20030235541-A1 Topical administration of basic antifungal compositions to treat fungal infections of the nails TECHNOLOGY RECOVERY SYSTEMS, LLC 2003-12-25 US disclosed